GB1375162A - - Google Patents

Info

Publication number
GB1375162A
GB1375162A GB963871*[A GB5035070A GB1375162A GB 1375162 A GB1375162 A GB 1375162A GB 5035070 A GB5035070 A GB 5035070A GB 1375162 A GB1375162 A GB 1375162A
Authority
GB
United Kingdom
Prior art keywords
group
formula
alkylthio
compounds
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB963871*[A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GB963871*[A priority Critical patent/GB1375162A/en
Priority to US00134876A priority patent/US3772289A/en
Priority to RO7168472A priority patent/RO67383A/ro
Priority to LU64129A priority patent/LU64129A1/xx
Priority to ZA717047A priority patent/ZA717047B/xx
Priority to BG18828A priority patent/BG20797A3/xx
Priority to DD167435A priority patent/DD100877A5/xx
Priority to MC951A priority patent/MC894A1/xx
Priority to CH1027675A priority patent/CH568302A5/xx
Priority to SU1707802A priority patent/SU429581A3/ru
Priority to BG21451A priority patent/BG20364A3/xx
Priority to JP8365271A priority patent/JPS5536662B1/ja
Priority to DD15846971A priority patent/DD94818A5/xx
Priority to CH1027775A priority patent/CH582681A5/xx
Priority to YU267871A priority patent/YU35002B/xx
Priority to ZM149/71A priority patent/ZM14971A1/xx
Priority to PH12953*UA priority patent/PH9226A/en
Priority to FR7137870A priority patent/FR2111769B1/fr
Priority to HUWE450A priority patent/HU166528B/hu
Priority to AU34863/71A priority patent/AU465145B2/en
Priority to DK513771A priority patent/DK132174C/da
Priority to AT909371A priority patent/AT319948B/de
Priority to BE774281A priority patent/BE774281A/xx
Priority to FI2975/71A priority patent/FI56175C/fi
Priority to ES396219A priority patent/ES396219A1/es
Priority to CA125,807A priority patent/CA967158A/en
Priority to SE7113328A priority patent/SE384505B/xx
Priority to IL45422A priority patent/IL45422A/en
Priority to IL37984A priority patent/IL37984A/en
Priority to AR238596A priority patent/AR192588A1/es
Priority to BG21452A priority patent/BG20365A3/xx
Priority to IE1329/71A priority patent/IE37452B1/xx
Priority to NLAANVRAGE7114494,A priority patent/NL175178C/xx
Priority to CH1532171A priority patent/CH568301A5/xx
Priority to NO391071A priority patent/NO134837C/no
Priority to DE19712152814 priority patent/DE2152814A1/de
Priority to AR242772A priority patent/AR192802A1/es
Priority to AR242773A priority patent/AR192803A1/es
Priority to BG21466A priority patent/BG21406A3/xx
Priority to KR7201836A priority patent/KR780000097B1/ko
Priority to SE7406661A priority patent/SE409705B/sv
Priority to GB2955374A priority patent/GB1375163A/en
Priority to CA205,203A priority patent/CA999583A/en
Publication of GB1375162A publication Critical patent/GB1375162A/en
Priority to JP15499477A priority patent/JPS53135991A/ja
Priority to YU186678A priority patent/YU186678A/xx
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB963871*[A 1970-10-22 1970-10-22 Expired GB1375162A (US08067413-20111129-C00029.png)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (US08067413-20111129-C00029.png) 1970-10-22 1970-10-22
US00134876A US3772289A (en) 1970-10-22 1971-04-16 Alkyl substituted benzyl pyrimidines
RO7168472A RO67383A (ro) 1970-10-22 1971-10-15 Procedeu pentru prepararea unor 2,4-diamino-5-benzilpirimidine
CH1027775A CH582681A5 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
ES396219A ES396219A1 (es) 1970-10-22 1971-10-21 Un metodo para preparar 2,4-diamino-5-bencilpirimidinas.
BG18828A BG20797A3 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
ZA717047A ZA717047B (en) 1970-10-22 1971-10-21 Organic compounds
MC951A MC894A1 (fr) 1970-10-22 1971-10-21 Benzil-pyrimidines et leur préparations
CH1027675A CH568302A5 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
SU1707802A SU429581A3 (ru) 1970-10-22 1971-10-21 Способ получения производных 2,4-диамино-5-бензил пиримидина12
BG21451A BG20364A3 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
JP8365271A JPS5536662B1 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
DD15846971A DD94818A5 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
FI2975/71A FI56175C (fi) 1970-10-22 1971-10-21 Foerfarande foer framstaellning av malaria foerhindrande och/eller baktericida 2,4-diamino-5-bensylpyrimidiner
YU267871A YU35002B (en) 1970-10-22 1971-10-21 Process for preparing 2,4-diamino-5-benzyl-pyrimidine
CA125,807A CA967158A (en) 1970-10-22 1971-10-21 Benzylpyrimidines
PH12953*UA PH9226A (en) 1970-10-22 1971-10-21 Alkyl substituted benzyl pyrimidines and pharmaceutical preparations thereof
FR7137870A FR2111769B1 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
HUWE450A HU166528B (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
AU34863/71A AU465145B2 (en) 1970-10-22 1971-10-21 2, 4-diamino-5-benzylpyrimidines
DK513771A DK132174C (da) 1970-10-22 1971-10-21 Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
AT909371A AT319948B (de) 1970-10-22 1971-10-21 Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen
BE774281A BE774281A (fr) 1970-10-22 1971-10-21 Nouveaux composes organiques
LU64129A LU64129A1 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
DD167435A DD100877A5 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
ZM149/71A ZM14971A1 (en) 1970-10-22 1971-10-21 Organic compounds
SE7113328A SE384505B (sv) 1970-10-22 1971-10-21 Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidinderivat
IL45422A IL45422A (en) 1970-10-22 1971-10-21 Alpha-(3,4,5-trisubstituted benzyl)-acrylonitriles and propionitriles and their preparation
IL37984A IL37984A (en) 1970-10-22 1971-10-21 2,4-diamino-5-benzylpyrimidine derivatives,their preparation and pharmaceutical compositions containing them
AR238596A AR192588A1 (es) 1970-10-22 1971-10-21 Un metodo para preparar derivados de pirimidina
BG21452A BG20365A3 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
IE1329/71A IE37452B1 (en) 1970-10-22 1971-10-21 2,4-diamino-5-benzylpyrimidines and processes for their production
NLAANVRAGE7114494,A NL175178C (nl) 1970-10-22 1971-10-21 Werkwijze om 2,4-diamino-5-benzylpyrimidinederivaten en farmaceutische preparaten die deze stoffen bevatten te bereiden.
CH1532171A CH568301A5 (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
NO391071A NO134837C (US08067413-20111129-C00029.png) 1970-10-22 1971-10-21
DE19712152814 DE2152814A1 (de) 1970-10-22 1971-10-22 Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung
AR242772A AR192802A1 (es) 1970-10-22 1972-06-27 Metodo para preparar 2,4-diamino-5-bencil-pirimidinas
AR242773A AR192803A1 (es) 1970-10-22 1972-06-27 Metodo para preparar 2,4-diamino-5-bencilpirimidinas
BG21466A BG21406A3 (US08067413-20111129-C00029.png) 1970-10-22 1972-10-21
KR7201836A KR780000097B1 (en) 1970-10-22 1972-12-05 A method of preparing 2.4-diamino-5-benzylpyrimidines
SE7406661A SE409705B (sv) 1970-10-22 1974-05-20 Vissa angivna nitrilforeningar till anvendning som mellanprodukter for framstellning av 2,4-diamino-5-bensylpyrimidiner med aktivitet mot malaria och bakterier
GB2955374A GB1375163A (US08067413-20111129-C00029.png) 1970-10-22 1974-07-03
CA205,203A CA999583A (en) 1970-10-22 1974-07-19 Intermediates for benzylpyrimides
JP15499477A JPS53135991A (en) 1970-10-22 1977-12-22 Method of producing 2*44diaminoo55 benzylpyrimidine
YU186678A YU186678A (en) 1970-10-22 1978-08-01 Process for producing 2,4-diamino-5-benzylpyrimidine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (US08067413-20111129-C00029.png) 1970-10-22 1970-10-22
GB963871 1971-04-16
GB4749171 1971-10-12

Publications (1)

Publication Number Publication Date
GB1375162A true GB1375162A (US08067413-20111129-C00029.png) 1974-11-27

Family

ID=27255400

Family Applications (1)

Application Number Title Priority Date Filing Date
GB963871*[A Expired GB1375162A (US08067413-20111129-C00029.png) 1970-10-22 1970-10-22

Country Status (20)

Country Link
JP (2) JPS5536662B1 (US08067413-20111129-C00029.png)
AR (3) AR192588A1 (US08067413-20111129-C00029.png)
AT (1) AT319948B (US08067413-20111129-C00029.png)
BE (1) BE774281A (US08067413-20111129-C00029.png)
BG (4) BG20365A3 (US08067413-20111129-C00029.png)
CA (1) CA967158A (US08067413-20111129-C00029.png)
CH (3) CH582681A5 (US08067413-20111129-C00029.png)
DD (1) DD100877A5 (US08067413-20111129-C00029.png)
DK (1) DK132174C (US08067413-20111129-C00029.png)
ES (1) ES396219A1 (US08067413-20111129-C00029.png)
FI (1) FI56175C (US08067413-20111129-C00029.png)
FR (1) FR2111769B1 (US08067413-20111129-C00029.png)
GB (1) GB1375162A (US08067413-20111129-C00029.png)
IE (1) IE37452B1 (US08067413-20111129-C00029.png)
IL (2) IL37984A (US08067413-20111129-C00029.png)
LU (1) LU64129A1 (US08067413-20111129-C00029.png)
MC (1) MC894A1 (US08067413-20111129-C00029.png)
NL (1) NL175178C (US08067413-20111129-C00029.png)
SE (2) SE384505B (US08067413-20111129-C00029.png)
ZM (1) ZM14971A1 (US08067413-20111129-C00029.png)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006987A1 (en) * 1978-05-24 1980-01-23 The Wellcome Foundation Limited 2,4-Diamino-5-benzylpyrimidines, especially for the treatment of microbial infections, pharmaceutical compositions containing these compounds and processes for preparing these compounds
WO2009067081A1 (en) * 2007-11-22 2009-05-28 Astrazeneca Ab Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis
US8044056B2 (en) 2007-03-20 2011-10-25 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound
US8063051B2 (en) 2007-03-19 2011-11-22 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
US8067413B2 (en) 2007-03-19 2011-11-29 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
US8067411B2 (en) 2006-12-14 2011-11-29 Astrazeneca Ab Compounds
US8138172B2 (en) 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
US8476288B2 (en) 2009-05-21 2013-07-02 Astrazeneca Ab Salts 756
US8575180B2 (en) 2004-03-26 2013-11-05 Astrazeneca Aktiebolag 9-substituted 8-oxoadenine compound
US8673907B2 (en) 2007-12-17 2014-03-18 Astrazeneca Ab Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
US8895570B2 (en) 2010-12-17 2014-11-25 Astrazeneca Ab Purine derivatives
US9045472B2 (en) 2010-12-16 2015-06-02 Astrazeneca Ab Imidazoquinoline compounds
US9376398B2 (en) 2012-05-18 2016-06-28 Sumitomo Dainippon Pharma Co., Ltd Carboxylic acid compounds
US9533978B2 (en) 2009-05-21 2017-01-03 Sumitomo Dainippon Pharma Co., Ltd Pyrimidine derivatives and their use in the treatment of cancer and further diseases

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
JPS61156909A (ja) * 1984-12-27 1986-07-16 Matsushita Electric Ind Co Ltd カレント・ミラ−回路
JPS62145907A (ja) * 1985-12-20 1987-06-30 Hitachi Ltd トランジスタ回路

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE710100A (US08067413-20111129-C00029.png) * 1967-02-02 1968-07-30
JPS511716A (ja) * 1974-06-25 1976-01-08 Toray Industries Horiesuterumaruchifuiramentono seiho

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006987A1 (en) * 1978-05-24 1980-01-23 The Wellcome Foundation Limited 2,4-Diamino-5-benzylpyrimidines, especially for the treatment of microbial infections, pharmaceutical compositions containing these compounds and processes for preparing these compounds
US8575180B2 (en) 2004-03-26 2013-11-05 Astrazeneca Aktiebolag 9-substituted 8-oxoadenine compound
US8969362B2 (en) 2004-03-26 2015-03-03 Astrazeneca Aktiebolag 9-substituted 8-oxoadenine compound
US8138172B2 (en) 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
US8067411B2 (en) 2006-12-14 2011-11-29 Astrazeneca Ab Compounds
US8063051B2 (en) 2007-03-19 2011-11-22 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
US8067413B2 (en) 2007-03-19 2011-11-29 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
US8044056B2 (en) 2007-03-20 2011-10-25 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound
US8268990B2 (en) 2007-11-22 2012-09-18 Astrazeneca Ab Compounds
CN101925584B (zh) * 2007-11-22 2013-04-17 阿斯利康(瑞典)有限公司 用于治疗哮喘、copd、过敏性鼻炎、过敏性结膜炎、特应性皮炎、癌症、乙型肝炎、丙型肝炎、hiv、hpv、细菌感染和皮肤病的嘧啶衍生物
EA018121B1 (ru) * 2007-11-22 2013-05-30 Астразенека Аб Производные пиримидина для лечения астмы, хобл, аллергического ринита, аллергического конъюнктивита, атопического дерматита, рака, гепатита в, гепатита с, вич, впч, бактериальных инфекций и дерматоза
CN103342682A (zh) * 2007-11-22 2013-10-09 阿斯利康(瑞典)有限公司 用于制备嘧啶衍生物的中间体
WO2009067081A1 (en) * 2007-11-22 2009-05-28 Astrazeneca Ab Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis
US8765939B2 (en) 2007-11-22 2014-07-01 Astrazeneca Ab Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers
US8673907B2 (en) 2007-12-17 2014-03-18 Astrazeneca Ab Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
US8476288B2 (en) 2009-05-21 2013-07-02 Astrazeneca Ab Salts 756
US9533978B2 (en) 2009-05-21 2017-01-03 Sumitomo Dainippon Pharma Co., Ltd Pyrimidine derivatives and their use in the treatment of cancer and further diseases
US9045472B2 (en) 2010-12-16 2015-06-02 Astrazeneca Ab Imidazoquinoline compounds
US8895570B2 (en) 2010-12-17 2014-11-25 Astrazeneca Ab Purine derivatives
US9376398B2 (en) 2012-05-18 2016-06-28 Sumitomo Dainippon Pharma Co., Ltd Carboxylic acid compounds
US10150743B2 (en) 2012-05-18 2018-12-11 Sumitomo Dainippon Pharma Co., Ltd. Carboxylic acid compounds
US10562861B2 (en) 2012-05-18 2020-02-18 Sumitomo Dainippon Pharma Co., Ltd. Carboxylic acid compounds
US11299465B2 (en) 2012-05-18 2022-04-12 Sumitomo Dainippon Pharma Co., Ltd. Carboxylic acid compounds

Also Published As

Publication number Publication date
AT319948B (de) 1975-01-10
IE37452L (en) 1972-04-22
JPS53135991A (en) 1978-11-28
NL175178B (nl) 1984-05-01
LU64129A1 (US08067413-20111129-C00029.png) 1972-06-28
IL45422A (en) 1976-03-31
DK132174B (da) 1975-11-03
AR192588A1 (es) 1973-02-28
AR192802A1 (es) 1973-03-14
MC894A1 (fr) 1972-06-22
DD100877A5 (US08067413-20111129-C00029.png) 1973-10-12
BG20364A3 (US08067413-20111129-C00029.png) 1975-11-05
BG20797A3 (US08067413-20111129-C00029.png) 1975-12-20
SE409705B (sv) 1979-09-03
FR2111769B1 (US08067413-20111129-C00029.png) 1974-10-18
FR2111769A1 (US08067413-20111129-C00029.png) 1972-06-09
CH582681A5 (US08067413-20111129-C00029.png) 1976-12-15
NL175178C (nl) 1984-10-01
CH568302A5 (US08067413-20111129-C00029.png) 1975-10-31
BE774281A (fr) 1972-04-21
AR192803A1 (es) 1973-03-14
CA967158A (en) 1975-05-06
NL7114494A (US08067413-20111129-C00029.png) 1972-04-25
IL37984A (en) 1976-03-31
CH568301A5 (US08067413-20111129-C00029.png) 1975-10-31
ES396219A1 (es) 1975-09-16
BG21406A3 (US08067413-20111129-C00029.png) 1976-05-20
IL37984A0 (en) 1971-12-29
BG20365A3 (US08067413-20111129-C00029.png) 1975-11-05
FI56175B (fi) 1979-08-31
JPS5536662B1 (US08067413-20111129-C00029.png) 1980-09-22
ZM14971A1 (en) 1972-07-21
FI56175C (fi) 1979-12-10
IE37452B1 (en) 1977-08-03
SE384505B (sv) 1976-05-10
DK132174C (da) 1976-03-29

Similar Documents

Publication Publication Date Title
GB1375162A (US08067413-20111129-C00029.png)
ES431775A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-aminoguanidina.
GB1332477A (en) Basic azo dyes free from sulphonic acid groups their production and use
GB1131191A (en) New imidazole derivatives, their preparation and use
GB1489595A (en) Bis-(triazinyl-amino)-stilbene-disulphonic acid derivatives
GB1409648A (en) Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof
GB1424492A (en) Pyrazol-5-ones their preparation and their pharmaceutical use
GB1392551A (en) Ergolene derivatives their preparation and use
GB1255633A (en) Halophenylalkylene amines and their use as algicides and slime bactericides
SE7413856L (US08067413-20111129-C00029.png)
US4335119A (en) Quick-acting diuretic compositions
GB1315849A (en) 1,2,3-trithiane derivatives
GB1152883A (en) 4,5-Polymethylene-Pyrimidine Derivatives
GB1325769A (en) Pyrimidopyridazine derivatives
US3134778A (en) 2,5,7-triamino-4-phenyl (or thienyl)-pyrimido[4,5-d]pyrimidines
ES381036A1 (es) Medicamentos analgesicos a base de n-(aroilalkil) n'-(alfa-nols) piperacinas y sus derivados, y procedimiento para su obtencion.
GB1511736A (en) Amidino-hydrazone derivatives of benzocycloalkanones
GB1305725A (US08067413-20111129-C00029.png)
GB1082964A (en) New substituted imidazolines and their preparation and use
GB1423465A (en) 1-phenyl-2-aminoalkyl imidazole derivatives and pharmaceutical compositions thereof
GB1473014A (en) 5-amino-4,5-dideoxy-ambutyrosin a
GB1240648A (en) N-substituted isatins
IL39218A (en) 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine its preparation and pharmaceutical compositions containing it
GB1453910A (en) Benzazepine derivatives
GB1339010A (en) Tetrazolyl-anthraquinone derivatives

Legal Events

Date Code Title Description
416 Proceeding under section 16 patents act 1949
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee